About Michael George, MD and Joan Meyer, Ph.D.

Dr. Joan Meyer is the Operational Strategy & Planning global therapeutic area head for Inflammation, Infectious Diseases and General Medicine, reporting in to the Covance office in Princeton, NJ. Dr. Meyer graduated from St. Mary’s University, Minnesota, with a BA in Biology and BA in Psychology. She received her Master of Science and PhD in Neuroscience from the University of Illinois at Urbana-Champaign. Dr. Meyer has more than 29 years of pharmaceutical and CRO experience, first joining Procter & Gamble, where she began her career in the research labs. While in the Clinical Development Division, Dr. Meyer led the development of drugs in the areas of arthritis, osteoporosis, gastrointestinal, urology, sleep and women’s health. Following Procter & Gamble, Dr. Meyer joined a global CRO with leadership positions in Project Management, Strategic Marketing and served as Global Head for Study Start Up.

Best Practices and Solutions in the New Inflammation Paradigm

Covance recently hosted a webinar “Best Practices and Solutions in the New Inflammation Paradigm,” where two Covance experts (Global Therapeutic Area Head for Inflammation Dr. Michael George and Executive Director of Operational Strategy and Planning Joan Meyer, Ph.D.) explored a profound shift in the perception and treatment of inflammation and its transformative impact on drug development and clinical trials.

Recent years have seen significant advances in the medical and scientific community’s knowledge of immunology and the pivotal role inflammation plays in disease, providing multiple new targets for anti-inflammatory therapy. A leading area of interest and activity, the global inflammatory therapeutics market is currently estimated at $55 billion per year and growing. Continue reading